Abdelwahid Awadalla, Almuazel Aalaa, Taglwy Malaz, Alzein Gawahir Murad Abdelrahman, Elnoor Ali Asim Abdelwahid, Mohammed Abdelbagi Ali Elbashir, Younis Reem A, Elhassan Ashruf Ishag Mohammed, Fathi Dina Mahmoud, Gurashi Ahazeej · International Journal of Artificial Intelligence and Machine Learning 2026 · 2026
DOI: 10.5281/zenodo.23276464
Counts differ because each database indexes a different set of publications. We treat OpenAlex as the canonical count; Google Scholar is not shown (no API, and crawling it violates its ToS).
Background: Explainable artificial intelligence (XAI) may support earlier detection of chronic disease, but Saudi-specific evidence has not been systematically characterized. Objective: To synthesize Saudi patient-level studies of AI/XAI for chronic-disease prediction and assess clinical readiness. Methods: PubMed and supplementary publisher-site, reference, and citation searches were completed on 26 August 2026. Eligible primary studies used Saudi clinical data for prediction, classification, or risk stratification. Findings were narratively synthesized and appraised with an adapted PROBAST framework. Results: Fifty-eight records were identified, 52 screened, nine assessed in full, and four included. Studies addressed chronic kidney disease, diabetic kidney disease, hypertension, and right-sided cardiac dysfunction. Reported discrimination was promising, with explicit SHAP-based explanations in three studies; however, all lacked independent external validation and had high overall risk of bias. Conclusion: Saudi XAI research is promising but clinically preliminary. Multicentre external validation, calibration, fairness evaluation, and prospective impact studies are required before routine deployment
No comments yet — start the discussion below.